JP2020510660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510660A5 JP2020510660A5 JP2019546918A JP2019546918A JP2020510660A5 JP 2020510660 A5 JP2020510660 A5 JP 2020510660A5 JP 2019546918 A JP2019546918 A JP 2019546918A JP 2019546918 A JP2019546918 A JP 2019546918A JP 2020510660 A5 JP2020510660 A5 JP 2020510660A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- excipient
- composition according
- aqueous medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017392A JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762465675P | 2017-03-01 | 2017-03-01 | |
| US62/465,675 | 2017-03-01 | ||
| US201762468832P | 2017-03-08 | 2017-03-08 | |
| US62/468,832 | 2017-03-08 | ||
| US201762526039P | 2017-06-28 | 2017-06-28 | |
| US62/526,039 | 2017-06-28 | ||
| US201762530515P | 2017-07-10 | 2017-07-10 | |
| US62/530,515 | 2017-07-10 | ||
| PCT/US2018/020519 WO2018160882A1 (en) | 2017-03-01 | 2018-03-01 | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017392A Division JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510660A JP2020510660A (ja) | 2020-04-09 |
| JP2020510660A5 true JP2020510660A5 (enExample) | 2021-03-25 |
| JP7023559B2 JP7023559B2 (ja) | 2022-02-22 |
Family
ID=61622823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019546918A Active JP7023559B2 (ja) | 2017-03-01 | 2018-03-01 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
| JP2022017392A Active JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017392A Active JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11123298B2 (enExample) |
| EP (2) | EP3977985B1 (enExample) |
| JP (2) | JP7023559B2 (enExample) |
| KR (2) | KR20220119169A (enExample) |
| CN (1) | CN110582271B (enExample) |
| AU (2) | AU2018227842B2 (enExample) |
| CA (1) | CA3054835A1 (enExample) |
| ES (2) | ES2897024T3 (enExample) |
| IL (1) | IL268997B2 (enExample) |
| MA (1) | MA47686A (enExample) |
| WO (1) | WO2018160882A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102441249B1 (ko) | 2014-10-23 | 2022-09-08 | 아레나 파마슈티칼스, 인크. | Ｐｇｉ2 수용체 관련 병태의 치료 방법 |
| KR20220119169A (ko) | 2017-03-01 | 2022-08-26 | 아레나 파마슈티칼스, 인크. | Pgi2-수용체 효능제를 포함하는 조성물 및 그의 제조 방법 |
| EP3796902A1 (en) | 2018-05-16 | 2021-03-31 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| WO2023158634A1 (en) | 2022-02-15 | 2023-08-24 | United Therapeutics Corporation | Crystalline prostacyclin (ip) receptor agonist and uses thereof |
| KR20250008015A (ko) * | 2023-07-06 | 2025-01-14 | 재단법인대구경북과학기술원 | 셀렉시팍을 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물 |
| WO2025193579A1 (en) | 2024-03-11 | 2025-09-18 | United Therapeutics Corporation | Methods of making ip-receptor agonists |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2945530A1 (de) | 1979-11-10 | 1981-06-04 | Chemische Werke Hüls AG, 4370 Marl | Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide |
| JPH03160438A (ja) | 1989-11-20 | 1991-07-10 | Konica Corp | ハロゲン化銀カラー写真感光材料 |
| EP0442448A3 (en) | 1990-02-13 | 1992-08-12 | Bristol-Myers Squibb Company | Heterocyclic carboxylic acids and esters |
| CA2085844A1 (en) | 1991-12-27 | 1993-06-28 | Nobuyuki Hamanaka | Fused benzeneoxyacetic acid derivatives |
| JPH06329598A (ja) | 1993-05-19 | 1994-11-29 | Daicel Chem Ind Ltd | エステルの製造方法 |
| DE4318889A1 (de) | 1993-06-07 | 1994-12-08 | Bayer Ag | Verfahren zur Herstellung von organischen Carbamaten |
| US5558071A (en) * | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
| RU2155188C2 (ru) | 1994-03-10 | 2000-08-27 | Фудзисава Фармасьютикал Со., Лтд. | Производные нафталина, фармацевтическая композиция |
| GT199800126A (es) | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
| JPH11269138A (ja) | 1998-03-20 | 1999-10-05 | Mitsubishi Paper Mills Ltd | 有機塩基発生剤 |
| US6335459B1 (en) | 1998-12-23 | 2002-01-01 | Syntex (U.S.A.) Llc | Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators |
| GB9908934D0 (en) | 1999-04-19 | 1999-06-16 | Rolic Ag | Liquid crystalline compounds |
| EP1046631A1 (en) | 1999-04-19 | 2000-10-25 | Rolic AG | Liquid crystalline compounds |
| US20040048844A1 (en) | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| EP1267912A2 (en) * | 2000-03-14 | 2003-01-02 | Burkhard Göke | Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| EP1265853A1 (en) | 2000-03-16 | 2002-12-18 | F. Hoffmann-La Roche AG | Carboxylic acid derivatives as ip antagonists |
| WO2002055484A1 (en) | 2001-01-12 | 2002-07-18 | Takeda Chemical Industries, Ltd. | Biaryl compound, process for producing the same, and agent |
| TWI316055B (enExample) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| AU2002322585A1 (en) | 2001-07-20 | 2003-03-03 | Adipogenix, Inc. | Fat accumulation-modulating compounds |
| BR0211810A (pt) | 2001-08-09 | 2004-08-24 | Ono Pharmaceutical Co | Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo |
| TW200307539A (en) | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
| US7086532B2 (en) | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
| TWI293715B (en) | 2002-10-10 | 2008-02-21 | Sipix Imaging Inc | A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display |
| CN1735598A (zh) | 2002-11-11 | 2006-02-15 | 拜耳医药保健股份公司 | 作为ip受体拮抗剂的苯基或杂芳基氨基烷烃衍生物 |
| KR20050101200A (ko) | 2003-02-10 | 2005-10-20 | 버텍스 파마슈티칼스 인코포레이티드 | Ｎ-아릴 카밤산 에스테르를 할로-헤테로아릴과반응시킴으로써 ｎ-헤테로아릴-ｎ-아릴-아민을 제조하는방법 및 유사 방법 |
| CN1191831C (zh) * | 2003-05-20 | 2005-03-09 | 广州贝氏药业有限公司 | 复方阿替洛尔硝苯地平缓释制剂 |
| GB0317498D0 (en) | 2003-07-25 | 2003-08-27 | Pfizer Ltd | Compounds |
| CN100402495C (zh) | 2003-09-22 | 2008-07-16 | 弗·哈夫曼-拉罗切有限公司 | 氨基烷基酰胺取代的环己基衍生物 |
| JP4402413B2 (ja) | 2003-09-29 | 2010-01-20 | 財団法人２１あおもり産業総合支援センター | Ｕ字型化合物およびこれを含む液晶組成物 |
| DE102004006785A1 (de) | 2004-02-11 | 2005-09-08 | Mayr, Herbert, Prof. Dr. | Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure |
| AU2005277203A1 (en) | 2004-08-20 | 2006-03-02 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| JP2006083085A (ja) | 2004-09-15 | 2006-03-30 | Kyowa Hakko Kogyo Co Ltd | 二環性ピリミジン誘導体の製造法およびその合成中間体 |
| JP4792731B2 (ja) | 2004-11-12 | 2011-10-12 | Ｄｉｃ株式会社 | 重合性液晶組成物及び当該組成物の硬化物 |
| WO2007051255A1 (en) | 2005-11-04 | 2007-05-10 | The University Of Sydney | Process for the preparation of compounds containing an azacyclic ring system |
| JP2007161867A (ja) | 2005-12-14 | 2007-06-28 | Toyo Ink Mfg Co Ltd | インキ組成物 |
| AU2007249827A1 (en) | 2006-05-09 | 2007-11-22 | Colorado State University Research Foundation | Methods for treating blood disorders |
| AR062659A1 (es) * | 2006-09-08 | 2008-11-26 | Drug Tech Corp | Composicion de liberacion sostenida de levodopa y metodo para su uso |
| KR101329658B1 (ko) * | 2006-09-25 | 2013-11-14 | 아처 다니엘 미드랜드 캄파니 | 초흡수성 표면처리된 카르복시알킬화 다당류 및 그 제조방법 |
| US20130084243A1 (en) * | 2010-01-27 | 2013-04-04 | Liliane Goetsch | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| KR20100052558A (ko) | 2007-09-12 | 2010-05-19 | 메르츠 파마 게엠베하 운트 코. 카가아 | 네라멕산을 위한 적정 패키지 및 내이 질환의 치료에서의 그의 용도 |
| ES2875944T3 (es) * | 2008-03-18 | 2021-11-11 | Arena Pharm Inc | Moduladores del receptor de prostaciclina (PG12) útiles para el tratamiento de trastornos relacionados con el mismo |
| EP2889029A1 (en) * | 2008-09-25 | 2015-07-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| EA022799B1 (ru) * | 2008-11-26 | 2016-03-31 | Арена Фармасьютикалз, Инк. | Пиразолилзамещенные производные угольной кислоты в качестве модуляторов рецептора простациклина (pgi2), применимые для лечения связанных с ним нарушений |
| PL2370413T3 (pl) | 2008-12-08 | 2016-01-29 | Arena Pharm Inc | Modulatory receptora prostacykliny (PGI2) użyteczne w leczeniu zaburzeń z nimi związanych |
| US20110028412A1 (en) * | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
| EP2480526A1 (en) | 2009-09-23 | 2012-08-01 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| KR102221846B1 (ko) * | 2014-04-07 | 2021-02-26 | 영진약품 주식회사 | 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법 |
| KR102441249B1 (ko) * | 2014-10-23 | 2022-09-08 | 아레나 파마슈티칼스, 인크. | Ｐｇｉ2 수용체 관련 병태의 치료 방법 |
| JP2019533713A (ja) | 2016-11-10 | 2019-11-21 | アレーナ ファーマシューティカルズ，インク． | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
| KR20220119169A (ko) | 2017-03-01 | 2022-08-26 | 아레나 파마슈티칼스, 인크. | Pgi2-수용체 효능제를 포함하는 조성물 및 그의 제조 방법 |
| EP3796902A1 (en) | 2018-05-16 | 2021-03-31 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
-
2018
- 2018-03-01 KR KR1020227027530A patent/KR20220119169A/ko not_active Ceased
- 2018-03-01 EP EP21192192.9A patent/EP3977985B1/en active Active
- 2018-03-01 CA CA3054835A patent/CA3054835A1/en active Pending
- 2018-03-01 WO PCT/US2018/020519 patent/WO2018160882A1/en not_active Ceased
- 2018-03-01 ES ES18710740T patent/ES2897024T3/es active Active
- 2018-03-01 JP JP2019546918A patent/JP7023559B2/ja active Active
- 2018-03-01 IL IL268997A patent/IL268997B2/en unknown
- 2018-03-01 KR KR1020197028214A patent/KR102432505B1/ko active Active
- 2018-03-01 MA MA047686A patent/MA47686A/fr unknown
- 2018-03-01 AU AU2018227842A patent/AU2018227842B2/en active Active
- 2018-03-01 ES ES21192192T patent/ES2965069T3/es active Active
- 2018-03-01 EP EP18710740.4A patent/EP3589274B1/en active Active
- 2018-03-01 CN CN201880029276.9A patent/CN110582271B/zh active Active
-
2019
- 2019-04-16 US US16/386,183 patent/US11123298B2/en active Active
-
2021
- 2021-08-12 US US17/400,957 patent/US11826471B2/en active Active
-
2022
- 2022-02-07 JP JP2022017392A patent/JP7498202B2/ja active Active
-
2023
- 2023-10-20 US US18/491,529 patent/US20240285537A1/en active Pending
-
2024
- 2024-05-13 AU AU2024203156A patent/AU2024203156A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510660A5 (enExample) | ||
| KR102024955B1 (ko) | 치환된 시클로부텐디온 항염 화합물의 콜린 염 | |
| JP2013501718A5 (enExample) | ||
| TW201446286A (zh) | 抗病毒化合物之固態分散調製劑 | |
| RU2017112308A (ru) | Композиции и способы для лечения бессонницы | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| US8753682B2 (en) | Dual release oral tablet compositions of dexlansoprazole | |
| US9114085B2 (en) | Modified release pharmaceutical compositions of dexlansoprazole | |
| JP2018516266A5 (enExample) | ||
| US8563035B2 (en) | Oral tablet compositions of dexlansoprazole | |
| CN102307575B (zh) | 含醋氯芬酸的控释口服药制剂及其制造方法 | |
| EP2641594B1 (en) | Enteric coated solid pharmaceutical compositions for proton pump inhibitors | |
| WO2012144964A1 (en) | Thiocolchicoside, diclofenac and lansoprazole combinations | |
| JP6781561B2 (ja) | プロピオン酸系非ステロイド性消炎鎮痛薬を含有した医薬組成物 | |
| JP2019516806A (ja) | 外層又は外側部分に存在するテストステロン化合物を有する薬物送達システムの調製方法及びそのような薬物送達システム | |
| JPWO2002066030A1 (ja) | ジクロフェナクとオルノプロスチルからなる医薬組成物 | |
| JP6334088B2 (ja) | 解熱鎮痛薬組成物 | |
| WO2014007777A1 (en) | Combined capsule formulations of nsaids | |
| EP3870176A2 (en) | Use of ambrisentan for the treatment of portal hypertension and cirrhosis | |
| JP6903252B2 (ja) | キサンチンオキシダーゼ阻害剤含有腸溶性製剤 | |
| WO2019098984A1 (en) | Synergistic combination of diclofenac, famotidine and a carbonate | |
| JPWO2019222764A5 (enExample) | ||
| CN108883074A (zh) | 含有他达拉非和坦索罗辛并具有改善的稳定性和溶出率的复合胶囊制剂 | |
| US10765668B2 (en) | Oral tablet composition comprising dexlansoprazole, oral tablet comprising the same and method for manufacturing the same | |
| AU2016381918B2 (en) | Compacted pharmaceutical preparation |